ArticleEMBO molecular medicine2026
A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid.
Nurlilah Ab Rahman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it